linagliptin and semaglutide Durability of Effectiveness Between Users of Once-Weekly Dipeptidyl Peptidase 4 Inhibitors (DPP–4i) in US Adults with Type 2 Diabetes | Diabetes Therapy Can linagliptin (Trajenta) be used

This guide breaks down everything known about both compounds, examines the theoretical case for combining them, maps the risks you need to understand, and provides the monitoring framework that any serious researcher would require before considering this stack

doi: 10.1002/cam4.3345 165 MukamaTSrourBJohnsonTKatzkeVKaaksR

The Type 2 Diabetes Mellitus segment held the largest share of 66.7% in 2025

A glycine-based compound would be a better fit

Population-level posterior predictions were generated at prespecified dose pairs, holding treatment duration constant at a representative value to ensure comparability across treatments